INTRANASAL INHALATIONS OF BIOACTIVE FACTORS PRODUCED BY M2 MACROPHAGES IN THE TREATMENT OF PATIENTS WITH ORGANIC BRAIN SYNDROME

The aim of present study was to evaluate safety and clinical efficacy of inhalatory immunotherapy based on intranasal delivery of bioactive factors produced by M2 macrophages applied for treatment of patients with organic brain syndrome (OBS).Materials and methods. The study under the NCT02957123 pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A. A. Ostanin, M. N. Davydova, N. M. Starostina, L. V. Sakhno, E. Ya. Shevela, E. R. Chernykh
Format: article
Langue:RU
Publié: SPb RAACI 2018
Sujets:
Accès en ligne:https://doaj.org/article/31c6d3581cc745bdb74b5ca50c7880a7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!